| Literature DB >> 31717554 |
Leticia Martín-Cordero1,2, Isabel Gálvez2,3, María Dolores Hinchado2,3, Eduardo Ortega2,3.
Abstract
Macrophages are crucial in the inflammation associated with obesity. Exercise is the main non-pharmacological strategy against obesity, not only for improving metabolic impairment, but also because of its anti-inflammatory effects, particularly those mediated by β2 adrenergic receptors (β2-AR). Nevertheless, these anti-inflammatory effects could immunocompromise the innate response against pathogen challenge. Thus, the objective of this work was to evaluate the effect of obesity, and of exercise in this condition, on the β2 adrenergic regulation of the innate function of macrophages. High fat diet-induced obese C57BL/6J mice were used to evaluate the effects of acute and regular exercise on the phagocytic and microbicide capacities of peritoneal macrophages. Selective β2-AR agonist terbutaline (1 µM) decreased the phagocytic and microbicide activities of macrophages from control lean and obese sedentary animals. While acute exercise did not modify the inhibitory capacity of terbutaline, regular exercise abolished this inhibitory effect. These effects cannot be explained only by changes in the surface expression of β2-AR. In conclusion, (1) obesity does not alter the β2-AR-mediated decrease of the innate response of macrophages and (2) regular exercise can revert the inhibitory effect of terbutaline on the phagocytic activity of macrophages, although obesity seems to hinder this immunophysiological adaptation.Entities:
Keywords: exercise; inflammation; innate response; macrophages; microbicide activity; obesity; phagocytosis; β2 adrenoreceptors
Mesh:
Substances:
Year: 2019 PMID: 31717554 PMCID: PMC6893822 DOI: 10.3390/nu11112721
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Schematic diagram of the experimental design of the study.
Body weight, dietary intake, and fasting blood glucose and lipid profile in lean and obese mice, without (sedentary) and with exercise, both acute and habitual (trained).
| Lean | Obese | |||||
|---|---|---|---|---|---|---|
| Sedentary | Acute Exercise | Trained | Sedentary | Acute Exercise | Trained | |
| Body Weight (g) | 29.3 ± 1.2 | 30.5 ± 2 | 25.6 ± 1 * | 42.3 ± 1.15 • | 39.8 ± 2 | 36.0 ± 3.0 * |
| Dietary Intake (g/day) | 4.0 ± 0.1 | 4.2 ± 0.1 | 4.1 ± 0.1 | 2.7 ± 0.1 • | 2.6 ± 0.1 | 2.5 ± 0.03 * |
| Energy Intake (Kj/day) | 55.32 ± 3.1 | 58.2 ± 1.4 | 56.6 ± 0.9 | 62.01 ± 2.7 • | 60.5 ± 1.9 | 57.6 ± 0.7 * |
| Glucose (mg/dL) | 218.9 ± 13.2 | 17 4± 32 * | 196.4 ± 25 | 311 ± 31 • | 222.7 ± 23 * | 282.5 ± 28 |
| Cholesterol (mg/dL) | ||||||
| Total Cholesterol | 103.7 ± 2.2 | <99 † | 106.7 ± 3 | 172.7 ± 19 • | 175 ± 42 | 178.1 ± 25 |
| HDL-C | 42.1 ± 2.9 | 51.7 ± 4 * | 59.7 ± 5.7 • | 55.5 ± 3 | 75.3 ± 4 * | |
| cLDL-C | 50.7 ± 3.5 | 88.0 ± 0 | 39.4 ± 2 * | 88.8 ± 16 • | 78 ± 12 | 38.5 ± 1 * |
| Triglycerides (mg/dL) | 86.8 ± 1.9 | 88.0 ± 0 | 76.6 ± 1 * | 91.5 ± 2 • | 98.7 ± 7 | 80 ± 1 * |
Each value represents the mean ± SEM of the determinations (one per independent animal) in duplicate. * p < 0.05 with respect to the corresponding sedentary group value; • p < 0.05 with respect to the lean sedentary group values. HDL-C, high-density lipoprotein cholesterol; cLDL-C, calculated low-density lipoprotein cholesterol; † below limit of detection.
Figure 2Effect of the β2-adrenergic agonist terbutaline and β2-adrenergic antagonist butaxamine on the phagocytic activity (mean fluorescence intensity, mfi) (A) and microbicide activity (mfi) (B) of peritoneal macrophages from lean and obese mice, expressed as the percentage change from baseline (giving “100” to control values in the absence of terbutaline and butaxamine). Columns represent the mean ± SEM of independent assays performed in duplicate. * p < 0.05 with respect to the corresponding control value; • p < 0.05 with respect to the corresponding terbutaline value.
Effect of the β2-adrenergic agonist terbutaline and β2-adrenergic antagonist butaxamine on the phagocytic percentage and microbicide percentage of peritoneal macrophages from lean and obese mice.
| Control | Terbutaline | Terbutaline + Butaxamine | ||
|---|---|---|---|---|
| Phagocytic percentage | lean | 85.3 ± 4 | 79.6 ± 3 * | 80.2 ± 4 |
| obese | 77.6 ± 5 | 71.9 ± 3 * | 78.3 ± 4 • | |
| Microbicide percentage | lean | 65.8 ± 7 | 64.9 ± 7 | 64.2 ± 8 |
| obese | 73.1 ± 8 | 67.6 ± 8 * | 67.7 ± 8 | |
Each value represents the mean ± SEM of independent assays performed in duplicate. * p < 0.05 with respect to the corresponding control value, in the absence of terbutaline and butaxamine; • p < 0.05 with respect to the corresponding terbutaline value.
Figure 3Effect of the β2-adrenergic agonist terbutaline on the phagocytic activity of peritoneal macrophages from lean (A) and obese (B) mice (sedentary, acute exercise, and trained mice). Effect of terbutaline expressed as percentage change from baseline (C). Columns represent the mean ± SEM of independent assays performed in duplicate. * p < 0.05 with respect to the corresponding control value, in the absence of terbutaline; • p < 0.05 with respect to the sedentary control group; ⊕ p < 0.05 with respect to the corresponding sedentary group.
Effect of the β2-adrenergic agonist terbutaline on the phagocytic percentage and microbicide percentage of peritoneal macrophages from lean and obese mice (sedentary, acute exercise, and trained mice).
| Sedentary | Acute Exercise | Trained | |||||
|---|---|---|---|---|---|---|---|
| Control | Terbutaline | Control | Terbutaline | Control | Terbutaline | ||
| Phagocytic percentage | lean | 85.3 ± 4 | 79.6 ± 3 * | 61.9 ± 5 • | 57.4 ± 6 * | 68.6 ± 11 | 67.9 ± 10 |
| obese | 77.6 ± 5 | 71.9 ± 3 * | 64.9 ± 1 • | 61.6 ± 2 * | 65.4 ± 1 | 65.7 ± 11 | |
| Microbicide percentage | lean | 65.8 ± 7 | 64.9 ± 7 | 57.7 ± 2 | 54.3 ± 15 | 71.7 ± 5 | 71.8 ± 6 |
| obese | 73.1 ± 8 | 67.6 ± 8 * | 74.8 ± 7 | 65.1 ± 5 * | 62.1 ± 6 | 61.9 ± 7 | |
Each value represents the mean ± SEM of independent assays performed in duplicate. * p < 0.05 with respect to the corresponding control value, in the absence of terbutaline; • p < 0.05 with respect to the sedentary control group.
Figure 4Effect of the β2-adrenergic agonist terbutaline on the microbicide activity of peritoneal macrophages from lean (A) and obese (B) mice (sedentary, acute exercise, and trained mice). Effect of terbutaline expressed as percentage change from the baseline (C). Columns represent the mean ± SEM of independent assays performed in duplicate. * p < 0.05 with respect to the corresponding control value, in the absence of terbutaline; ⊕ p < 0.05 with respect to the corresponding sedentary group.
Influence of exercise on the relative effect of the β2-adrenergic agonist terbutaline on the phagocytic and microbicide percentages of peritoneal macrophages from lean and obese mice (sedentary, acute exercise, and trained mice) (giving 100 to control values in the absence of terbutaline).
| Without Terbutaline | With Terbutaline | ||||
|---|---|---|---|---|---|
| Sedentary | Acute Exercise | Trained | |||
| Phagocytic percentage | lean | 100 | 93.5 ± 2 | 92.4 ± 2 | 99.1 ± 3 • |
| obese | 100 | 93.3 ± 3 | 94.9 ± 3 | 100.5 ± 2 • | |
| Microbicide percentage | lean | 100 | 98.2 ± 4 | 93.3 ± 3 | 100.5 ± 4 |
| obese | 100 | 91.1 ± 4 | 87.5 ± 4 | 99.2 ± 3 • | |
Each value represents the mean ± SEM of independent assays performed in duplicate. • p < 0.05 with respect to the corresponding sedentary group.
Figure 5Effect of exercise on the expression of β2-adrenergic receptor in peritoneal macrophages from lean and obese mice (sedentary, acute exercise, and trained mice). Each dot represents the individual values obtained in duplicate in each animal, and the horizontal line represents the mean. * p < 0.05 with respect to the corresponding sedentary group; ● p < 0.05 with respect to the lean sedentary group.